These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35995384)

  • 1. Targeted proteomics using parallel reaction monitoring confirms salivary proteins indicative of metastatic triple-negative breast cancer.
    Giri K; Maity S; Ambatipudi K
    J Proteomics; 2022 Sep; 267():104701. PubMed ID: 35995384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
    Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
    J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
    Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
    J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted Proteomics Guided by Label-free Quantitative Proteome Analysis in Saliva Reveal Transition Signatures from Health to Periodontal Disease.
    Bostanci N; Selevsek N; Wolski W; Grossmann J; Bao K; Wahlander A; Trachsel C; Schlapbach R; Öztürk VÖ; Afacan B; Emingil G; Belibasakis GN
    Mol Cell Proteomics; 2018 Jul; 17(7):1392-1409. PubMed ID: 29610270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.
    Gámez-Pozo A; Trilla-Fuertes L; Prado-Vázquez G; Chiva C; López-Vacas R; Nanni P; Berges-Soria J; Grossmann J; Díaz-Almirón M; Ciruelos E; Sabidó E; Espinosa E; Fresno Vara JÁ
    PLoS One; 2017; 12(6):e0178296. PubMed ID: 28594844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative Pattern of hPTMs by Mass Spectrometry-Based Proteomics with Implications for Triple-Negative Breast Cancer.
    Liu C; Xu M; Li W; Cao X; Wang Y; Chen H; Zhang T; Lu M; Xie H; Chen Y
    J Proteome Res; 2024 Apr; 23(4):1495-1505. PubMed ID: 38576392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
    Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
    Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precise diagnosis and typing of early-stage renal immunoglobulin-derived amyloidosis by label-free quantification of parallel reaction monitoring-based targeted proteomics.
    Li Y; Zhang Y; Zhou X; Xue X; Wang M; Kang D; Zhou Y; Hu R; Quan S; Xing G; Yang J
    BMC Nephrol; 2023 Mar; 24(1):50. PubMed ID: 36894904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.
    Liu AN; Sun P; Liu JN; Yu CY; Qu HJ; Jiao AH; Zhang LM
    Tumour Biol; 2014 Oct; 35(10):9751-7. PubMed ID: 24972967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iTRAQ-based quantitative analysis of age-specific variations in salivary proteome of caries-susceptible individuals.
    Wang K; Wang X; Zheng S; Niu Y; Zheng W; Qin X; Li Z; Luo J; Jiang W; Zhou X; Li W; Zhang L
    J Transl Med; 2018 Oct; 16(1):293. PubMed ID: 30359274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic identification of salivary biomarkers of type-2 diabetes.
    Rao PV; Reddy AP; Lu X; Dasari S; Krishnaprasad A; Biggs E; Roberts CT; Nagalla SR
    J Proteome Res; 2009 Jan; 8(1):239-45. PubMed ID: 19118452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iTRAQ-Based Quantitative Proteomic Analysis Strengthens Transcriptomic Subtyping of Triple-Negative Breast Cancer Tumors.
    Jézéquel P; Guette C; Lasla H; Gouraud W; Boissard A; Guérin-Charbonnel C; Campone M
    Proteomics; 2019 Nov; 19(21-22):e1800484. PubMed ID: 30951236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Technical considerations for large-scale parallel reaction monitoring analysis.
    Gallien S; Bourmaud A; Kim SY; Domon B
    J Proteomics; 2014 Apr; 100():147-59. PubMed ID: 24200835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability Assessment of 90 Salivary Proteins in Intraday and Interday Samples from Healthy Donors by Multiple Reaction Monitoring-Mass Spectrometry.
    Hsiao YC; Chu LJ; Chen YT; Chi LM; Chien KY; Chiang WF; Chang YT; Chen SF; Wang WS; Chuang YN; Lin SY; Chien CY; Chang KP; Chang YS; Yu JS
    Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29350471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of WNT/β-catenin, c-Met, and integrin signalling pathways by miR-193b controls triple negative breast cancer metastatic traits.
    Giacomelli C; Jung J; Wachter A; Ibing S; Will R; Uhlmann S; Mannsperger H; Sahin Ö; Yarden Y; Beißbarth T; Korf U; Körner C; Wiemann S
    BMC Cancer; 2021 Dec; 21(1):1296. PubMed ID: 34863149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.
    Quintero M; Adamoski D; Reis LMD; Ascenção CFR; Oliveira KRS; Gonçalves KA; Dias MM; Carazzolle MF; Dias SMG
    BMC Cancer; 2017 Nov; 17(1):727. PubMed ID: 29115931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic Landscape of Exosomes Reveals the Functional Contributions of CD151 in Triple-Negative Breast Cancer.
    Li S; Li X; Yang S; Pi H; Li Z; Yao P; Zhang Q; Wang Q; Shen P; Li X; Ji J
    Mol Cell Proteomics; 2021; 20():100121. PubMed ID: 34265469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic exposure to multiple stressors alters the salivary proteome of piglets.
    Prims S; Van Ostade X; Ayuso M; Dom M; Van Raemdonck G; Van Cruchten S; Casteleyn C; Van Ginneken C
    PLoS One; 2023; 18(5):e0286455. PubMed ID: 37235602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome profiling of triple negative breast cancer cells overexpressing NOD1 and NOD2 receptors unveils molecular signatures of malignant cell proliferation.
    Velloso FJ; Campos AR; Sogayar MC; Correa RG
    BMC Genomics; 2019 Feb; 20(1):152. PubMed ID: 30791886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic Analysis Revealed the Potential Role of MAGE-D2 in the Therapeutic Targeting of Triple-Negative Breast Cancer.
    Shi X; Liu C; Zheng W; Cao X; Li W; Zhang D; Zhu J; Zhang X; Chen Y
    Mol Cell Proteomics; 2024 Jan; 23(1):100703. PubMed ID: 38128647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.